These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 10087018

  • 1. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
    McLaughlin JP, Hill KP, Jiang Q, Sebastian A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
    [Abstract] [Full Text] [Related]

  • 2. 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists.
    Jiang Q, Sebastian A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1107-13. PubMed ID: 7511163
    [Abstract] [Full Text] [Related]

  • 3. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
    Zernig G, Burke T, Lewis JW, Woods JH.
    J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
    [Abstract] [Full Text] [Related]

  • 5. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY, Seyed-Mozaffari A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [Abstract] [Full Text] [Related]

  • 6. Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
    Burke TF, Woods JH, Lewis JW, Medzihradsky F.
    J Pharmacol Exp Ther; 1994 Nov; 271(2):715-21. PubMed ID: 7965787
    [Abstract] [Full Text] [Related]

  • 7. Preventing morphine antinociceptive tolerance by irreversible mu opioid antagonists before the onset of their antagonism.
    Jiang Q, Seyed-Mozaffari A, Sebastian A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1995 May; 273(2):680-8. PubMed ID: 7752070
    [Abstract] [Full Text] [Related]

  • 8. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH, Sumpter TL, Burke TF, Husbands SM, Lewis JW, Woods JH, Traynor JR.
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [Abstract] [Full Text] [Related]

  • 9. 14 beta-Chlorocinnamoylamino derivatives of metopon: long-term mu-opioid receptor antagonists.
    McLaughlin JP, Sebastian A, Archer S, Bidlack JM.
    Eur J Pharmacol; 1997 Feb 12; 320(2-3):121-9. PubMed ID: 9059844
    [Abstract] [Full Text] [Related]

  • 10. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN, Walker EA.
    J Pharmacol Exp Ther; 2003 Jan 12; 304(1):301-9. PubMed ID: 12490605
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF, Collins KA.
    J Pharmacol Exp Ther; 1996 Oct 12; 279(1):39-46. PubMed ID: 8858973
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
    Jiang Q, Seyed-Mozaffari A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1993 Mar 12; 264(3):1021-7. PubMed ID: 7680715
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
    Mathews JL, Peng X, Xiong W, Zhang A, Negus SS, Neumeyer JL, Bidlack JM.
    J Pharmacol Exp Ther; 2005 Nov 12; 315(2):821-7. PubMed ID: 16076937
    [Abstract] [Full Text] [Related]

  • 14. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 12; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 15. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
    Qi JA, Bowen WD, Mosberg HI, Rothman RB, Porreca F.
    J Pharmacol Exp Ther; 1990 Nov 12; 255(2):636-41. PubMed ID: 2173752
    [Abstract] [Full Text] [Related]

  • 16. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H, Spaulding A, Leitermann R, Wu HE, Nagase H, Tseng LF.
    J Pharmacol Exp Ther; 2003 Jul 12; 306(1):394-400. PubMed ID: 12721333
    [Abstract] [Full Text] [Related]

  • 17. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F.
    J Pharmacol Exp Ther; 1996 Apr 12; 277(1):484-90. PubMed ID: 8613958
    [Abstract] [Full Text] [Related]

  • 18. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
    Heyman JS, Williams CL, Burks TF, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1988 Apr 12; 245(1):238-43. PubMed ID: 2834537
    [Abstract] [Full Text] [Related]

  • 19. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K, Varga EV, Alfaro-Lopez J, Tang X, Vanderah TW, Porreca F, Hruby VJ, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 2003 Feb 12; 304(2):683-8. PubMed ID: 12538822
    [Abstract] [Full Text] [Related]

  • 20. Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO).
    Jiang Q, Seyed-Mozaffari A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1992 Aug 12; 262(2):526-31. PubMed ID: 1380079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.